Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
January 9, 1998
Fraction size and dose parameters related to the incidence of pericardial effusions
M K Martel, W M Sahijdak, R K Ten Haken, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 1, 1996
Analysis of localization errors in the definition of the mantle field using a beam's eye view treatment-planning system
J D Naida, A Eisbruch, S L Schoeppel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 1, 1997
Volume and dose parameters for survival of non-small cell lung cancer patients
M K Martel, M Strawderman, M B Hazuka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1993
Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group
D H Johnson, A T Turrisi, A Y Chang, et al.
Pediatric Neurosurgery
|
January 1, 1995
Pediatric midbrain tumors: a benign subgroup of brainstem gliomas
P L Robertson, K M Muraszko, J A Brunberg, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 1988
Final report on phase I trial of WR-2721 before protracted fractionated radiation therapy
M M Kligerman, A T Turrisi, R C Urtasun, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 1994
Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis
M K Martel, R K Ten Haken, M B Hazuka, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 1, 1986
Human pharmacokinetics of WR-2721
L M Shaw, A T Turrisi, D J Glover, et al.
Cancer Treatment Reports
|
December 1, 1986
Final report of the phase I trial of single-dose WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid]
A T Turrisi, D J Glover, S Hurwitz, et al.
The New England Journal of Medicine
|
January 28, 1999
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
A T Turrisi, K Kim, R Blum, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
International Journal of Radiation Oncology, Biology, Physics
|
January 9, 1998
Fraction size and dose parameters related to the incidence of pericardial effusions
M K Martel, W M Sahijdak, R K Ten Haken, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 1, 1996
Analysis of localization errors in the definition of the mantle field using a beam's eye view treatment-planning system
J D Naida, A Eisbruch, S L Schoeppel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 1, 1997
Volume and dose parameters for survival of non-small cell lung cancer patients
M K Martel, M Strawderman, M B Hazuka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1993
Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group
D H Johnson, A T Turrisi, A Y Chang, et al.
Pediatric Neurosurgery
|
January 1, 1995
Pediatric midbrain tumors: a benign subgroup of brainstem gliomas
P L Robertson, K M Muraszko, J A Brunberg, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 1988
Final report on phase I trial of WR-2721 before protracted fractionated radiation therapy
M M Kligerman, A T Turrisi, R C Urtasun, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 1994
Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis
M K Martel, R K Ten Haken, M B Hazuka, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 1, 1986
Human pharmacokinetics of WR-2721
L M Shaw, A T Turrisi, D J Glover, et al.
Cancer Treatment Reports
|
December 1, 1986
Final report of the phase I trial of single-dose WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid]
A T Turrisi, D J Glover, S Hurwitz, et al.
The New England Journal of Medicine
|
January 28, 1999
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
A T Turrisi, K Kim, R Blum, et al.
Page
of 7